Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk
Wenxuan Huo1,2, Chuanhe Jiang3, Congxiao Zhang4
1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Blood Cancer Journal
|April 2, 2026
Abstract
No abstract available in PubMed .


